Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$25,040
-7.14%
Shares
Shares Volume: 1,000 Shares
Average Share Price: $25.04
INSIDER
Hohl Benjamin
CHIEF FINANCIAL OFFICER (Officer)
reported on Jan 7 2025
traded on Dec 13 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 13,000 |
| PURCHASES/SALES 1Y | 0 / 20 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $103,228.02 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 88 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $932,340.68 |
| COMPANY PREVIOUS TRADES |